IL198170A0 - Robust sustained release formulations of oxymorphone and methods of use thereof - Google Patents

Robust sustained release formulations of oxymorphone and methods of use thereof

Info

Publication number
IL198170A0
IL198170A0 IL198170A IL19817009A IL198170A0 IL 198170 A0 IL198170 A0 IL 198170A0 IL 198170 A IL198170 A IL 198170A IL 19817009 A IL19817009 A IL 19817009A IL 198170 A0 IL198170 A0 IL 198170A0
Authority
IL
Israel
Prior art keywords
oxymorphone
methods
sustained release
release formulations
robust sustained
Prior art date
Application number
IL198170A
Original Assignee
Penwest Pharmaceuticals Compan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38134325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL198170(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Penwest Pharmaceuticals Compan filed Critical Penwest Pharmaceuticals Compan
Publication of IL198170A0 publication Critical patent/IL198170A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL198170A 2006-10-10 2009-04-16 Robust sustained release formulations of oxymorphone and methods of use thereof IL198170A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/039781 WO2008045047A1 (en) 2006-10-10 2006-10-10 Robust sustained release formulations of oxymorphone and methods of use thereof

Publications (1)

Publication Number Publication Date
IL198170A0 true IL198170A0 (en) 2009-12-24

Family

ID=38134325

Family Applications (1)

Application Number Title Priority Date Filing Date
IL198170A IL198170A0 (en) 2006-10-10 2009-04-16 Robust sustained release formulations of oxymorphone and methods of use thereof

Country Status (9)

Country Link
EP (1) EP2097070A1 (en)
JP (1) JP2010505948A (en)
CN (1) CN101578094A (en)
AU (1) AU2006349472A1 (en)
BR (1) BRPI0621951A2 (en)
CA (1) CA2653017A1 (en)
IL (1) IL198170A0 (en)
MX (1) MX2009003770A (en)
WO (1) WO2008045047A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004031A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
BRPI0621952A2 (en) * 2006-10-10 2011-10-18 Penwest Pharmaceutical Co robust formulations with prolonged release of oxymorphone and methods of using them
CN104622791A (en) * 2015-02-13 2015-05-20 扬子江药业集团有限公司 Dezocine oral preparation
EP3473246A1 (en) 2017-10-19 2019-04-24 Capsugel Belgium NV Immediate release abuse deterrent formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030048026A (en) * 2001-07-06 2003-06-18 펜웨스트 파머슈티칼즈 컴파니 Sustained release formulations of oxymorphone
WO2003004031A1 (en) * 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
EP1429730A4 (en) * 2001-09-26 2010-06-16 Penwest Pharmaceuticals Compan Opioid formulations having reduced potential for abuse
BRPI0621952A2 (en) * 2006-10-10 2011-10-18 Penwest Pharmaceutical Co robust formulations with prolonged release of oxymorphone and methods of using them

Also Published As

Publication number Publication date
MX2009003770A (en) 2009-07-22
WO2008045047A1 (en) 2008-04-17
AU2006349472A1 (en) 2008-04-17
JP2010505948A (en) 2010-02-25
EP2097070A1 (en) 2009-09-09
CA2653017A1 (en) 2008-04-17
CN101578094A (en) 2009-11-11
BRPI0621951A2 (en) 2011-10-18

Similar Documents

Publication Publication Date Title
EP2043647A4 (en) Controlled release formulations and associated methods
ZA200707440B (en) Compositions and methods of making sustained release liquid formulations
EP2021455A4 (en) Cytoblock preparation system and methods of use
IL198168A0 (en) Robust sustained release formulations
HUE053838T2 (en) Sustained release formulations of nalbuphine
EP2024476A4 (en) Compositions comprising low-dp polymerized surfactants and methods of use thereof
IL216401A0 (en) Sustained release of antinfectives
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
HK1213814A1 (en) Diclofenac formulations and methods of use
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
EP2023718A4 (en) Creatine-ligand compounds and methods of use thereof
IL184735A0 (en) Pharmaceutical formulations and methods of use
IL193693A0 (en) Purine compounds and methods of use thereof
ZA200808017B (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
EP2117607A4 (en) Imaging agents and methods of use thereof
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
EP1895991A4 (en) Modified release formulations of anti-irritability drugs
EP2173822A4 (en) Ink formulations and methods of making ink formulations
EP2160183A4 (en) Extended release formulations comprising quetipine and methods for their manufacture
ZA201004489B (en) Release agent formulas and methods
ZA201102518B (en) Modified release formulation and methods of use
EP2167522A4 (en) Triazole-based aminoglycoside-peptide conjugates and methods of use
EP2069452A4 (en) Onium-containing cmp compositions and methods of use thereof
EP2021448A4 (en) Compositions comprising low-dp polymerized surfactants and methods of use thereof
ZA200907727B (en) Cinnamaldehyde formulations and methods of use